ARCHIVES

DCT’s Experimental Therapeutic Program Outlined to Board

This article is from The Cancer Letter archive.

Vol. 01 No. 18 | May 2, 1975

Download PDF Visit The Full Archive

Related Articles

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

April 29, 2011

NIH Forming Special Emphasis Panel To Review Clinical Oncology Grants

September 18, 1998

FDA Revises Package Insert, Seeks To Limit Product Liability Suits In State Courts.

January 20, 2006

AACR Calls For Clear Statement; Says Report Was “Premature”

February 14, 1997

RFA, “New Approaches In Surgical Oncology” Announced By DCT

December 1, 1978

Pediatric Oncology Groups Plan To Merge, Citing Greater Cost Efficiencies, Leverage

August 7, 1998